Chronic myeloid leukemia (CML) is a hematopoietic malignancy … the bone marrow microenvironment of chronic myeloid leukemia. Genes & Diseases. doi.org …

Video content above is prompted by the following: The NCCN guidelines establish clear first-line treatment options for CML, including imatinib and second-generation tyrosine kinase inhibitors such as nilotinib. Close monitoring protocols are essential for …

… of people with leukemia have chronic myeloid leukemia (CML), which has seen a …

… the treatment of patients with chronic myeloid leukemia (CML). Since the introduction of …

… of Patients with Chronic Myeloid Leukemia Relationship Between Dasatinib … treatment with dasatinib in chronic myeloid leukemia: characteristics, potential mechanisms, … in vitro models of chronic myeloid leukemia show different characteristics: …

… , which is known to cause chronic myeloid leukemia. The team investigated when BCR … our study suggests is that chronic myeloid leukemia is an outlier compared to … cancers. We have shown that chronic myeloid leukemia cells undergo incredibly rapid growth …

… stable deep molecular remission of chronic myeloid leukemia (CML), which will help to … and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and …

… remission in patients suffering from chronic myeloid leukemia (CML). This advancement is … decisions for patients with chronic myeloid leukemia. As research continues to … Credits: None provided. Keywords: Chronic Myeloid Leukemia, Digital PCR, BCR::ABL1, …

… on the results obtained in chronic myeloid leukemia [CML], at the end of …

… patient population with chronic phase chronic myeloid leukemia,” published in the March 2025 … -line treatments for chronic phase chronic myeloid leukemia (CML-CP) with similar efficacy …